- Bobin, C
- Bouchard, J
- Chisté, V
- Collins, S M
- Dryák, P
- Fenwick, A
- Keightley, J
- Lépy, M-C
- Lourenço, V
-
Robinson, A P
Autor Robinson, A P National Physical Laboratory, Hampton Road, Teddington, Middlesex, TW11 0LW, United Kingdom University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom Christie Medical Physics and Engineering (CMPE), The Christie NHS Foundation Trust, Wilmslow Road, M20 4BX, Manchester, United Kingdom
Holmium-166 is a high-energy β--emitter radionuclide (~ 1.8 MeV) with a short half-life (~26.8h) that offers great potential as an alternative to 90Y for the treatment of liver cancer based on radioembolization. The possibility of quantitative Single Photon Emission Computed Tomography (SPECT) imaging of the main γ-ray emission at 80.6 keV, in addition to strong paramagnetic properties suitable for Magnetic Resonance Imaging (MRI), complement this therapeutic potential. The present paper describes the measurements carried out in three European radionuclide metrology laboratories for primary standardization of 166Ho and new determinations of X- and γ-ray photon-emission intensities in the framework of the European EMPIR project MRTDosimetry. New half-life measurements were also performed.
- MeSH
- dávka záření * MeSH
- holmium analýza MeSH
- jednofotonová emisní výpočetní tomografie MeSH
- lidé MeSH
- nádory jater diagnostické zobrazování radioterapie MeSH
- radionuklidy analýza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.